Innominds & SCIINV Biosciences Launch AI-Powered Tool To Tackle Antimicrobial Resistance

Innominds and SCIINV Biosciences have partnered to introduce AMRx, an AI/ML-driven digital diagnostic tool to combat antimicrobial resistance (AMR). AMRx uses artificial intelligence and machine learning to predict urinary tract infections (UTIs) and identify antibiotic resistance patterns based on patient clinical history. This culture-free approach saves time and resources, especially in settings with limited medical infrastructure. AMRx can support clinical decision-making by providing accurate data for empirical antibiotic prescriptions, potentially improving treatment outcomes. Early diagnosis and treatment are crucial for improving patient outcomes and reducing the spread of antibiotic-resistant bacteria.